Brainsway Ltd. Sponsored ADR

BWAY Healthcare Medical Devices

Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024.

Revenue
+35.4%
EPS
+40.0%
Free cash flow
−51.7%

Quarter to June 2026, against a year earlier

11.14 0.53 +5.00%
Market cap
$427.1M
P/E
21.2×
Fwd P/E
0.0×
Dividend yield
—
F-score
6/9
Altman Z
2.82
Beneish M
−2.45
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 6 6 6
ROE
10.95% 11.18% 12.55% 12.82%
ROA
6.75% 7.30% 8.06% 8.09%
ROIC
0.00% 71.48% 22.79% 29.98%
Return on Tangible Assets
10.82% 12.19% 15.65% 15.84%
Average Days of Receivables
38.13 28.73 48.89 42.29
Free Cash Flow per Share
0.94 0.80 0.61 0.30
Free Cash Flow
18.34 15.15 11.58 5.79
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026